Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

NCT03878550 is registered in ClinicalTrials.gov with Glycotest, Inc. as lead sponsor.

NCT NCT03878550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03878550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Lead sponsor
Glycotest, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
May 22, 2019
Completion date
December 31, 2027
Enrollment
766 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, cirrhosis, liver